BOND ORACLE HER2 IHC SYSTEM
Report
- Report Number
- 3004859032-2015-00002
- Event Type
- Malfunction
- Date Received
- October 13, 2015
- Manufacturer
- LEICA BIOSYSTEMS NEWCASTLE LTD.
- Product Code
- MVC
- PMA / PMN Number
- P090015
- Report Source
- Manufacturer report
- Reporter Location
- NL
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
ON (B)(4) 2016, LEICA BIOSYSTEMS WERE GIVEN THE FOLLOWING INFORMATION. IMAGES OF CELL LINES FROM LOT 27595 HAVE BEEN SENT TO THE (B)(4) FACILITY TO REVIEW. FURTHER CORRESPONDENCE IS TO BE SENT TO THE CUSTOMER TO REQUEST THE IN HOUSE CONTROL SLIDES, PATIENT SAMPLES AND CELL LINES FOR LOTS UNDER COMPLAINT. THIS WILL AID THE INVESTIGATION.
THE PATIENT AND CONTROL SLIDES HAVE BEEN RETURNED TO THE MANUFACTURER. THE PATIENT SLIDES DEMONSTRATE POSITIVE STAINING WHICH INDICATES A POSITIVE RESULT FOR HER2. THE PRODUCT HAS PERFORMED AS INTENDED AND INDICATES NO MALFUNCTION. THE CUSTOMER CONFIRMED THE PRODUCT LOT WHICH WAS USED FOR THE 3 PATIENT SLIDES WAS 27595. THE DEVICE HAD BEEN UTILISED.
LEICA BIOSYSTEMS WAS INFORMED ON 09/14/2015 THAT 2 BATCHES OF BOND ORACLE HER2 IHC SYSTEM WERE USED FOR TESTING PATIENT SAMPLES. A REVIEW OF THE RESULTS AND FURTHER TESTING BY THE HEALTHCARE PROFESSIONAL DEMONSTRATED 3 PATIENTS SAMPLES MAY HAVE GIVEN A FALSE NEGATIVE RESULT.
LEICA BIOSYSTEMS WAS INFORMED ON (B)(6) 2015, THAT 2 BATCHES OF BOND ORACLE HER2 IHC SYSTEM - PRODUCT CODE TA9145 (LOTS 27595 AND 20871) WERE USED FOR TESTING PATIENT SAMPLES. A REVIEW OF THE RESULTS AND FURTHER TESTING BY HEALTHCARE PROFESSIONAL DEMONSTRATED 3 PATIENTS SAMPLES MAY HAVE GIVEN A FALSE NEGATIVE RESULT. LEICA BIOSYSTEMS NEW CASTLE LTD HAVE REQUESTED FURTHER INFORMATION TO AID IN THE INVESTIGATION, TO DATE NO INFORMATION HAS BEEN RECEIVED.
LEICA BIOSYSTEMS WAS INFORMED ON 14 SEPTEMBER 2015 THAT 2 BATCHES OF BOND¿ ORACLE¿ HER2 IHC SYSTEM - PRODUCT CODE TA9145 (LOTS 27595 AND 20871) WERE USED FOR TESTING PATIENT SAMPLES. A REVIEW OF THE RESULTS AND FURTHER TESTING BY THE HEALTHCARE PROFESSIONAL DEMONSTRATED 3 PATIENTS SAMPLES MAY HAVE GIVEN A FALSE NEGATIVE RESULT.
ON (B)(4) 2016, LEICA BIOSYSTEMS WERE GIVEN THE FOLLOWING INFORMATION. IMAGES OF CELL LINES FROM LOT 27595 HAVE BEEN SENT TO THE (B)(4) FACILITY TO REVIEW. FURTHER CORRESPONDENCE IS TO BE SENT TO THE CUSTOMER TO REQUEST THE IN HOUSE CONTROL SLIDES, PATIENT SAMPLES AND CELL LINES FOR LOTS UNDER COMPLAINT. THIS WILL AID THE INVESTIGATION.
ON (B)(4) 2016, LEICA BIOSYSTEMS WERE GIVEN THE FOLLOWING INFORMATION. IMAGES OF CELL LINES FROM LOT 27595 HAVE BEEN SENT TO THE (B)(4) FACILITY TO REVIEW. FURTHER CORRESPONDENCE IS TO BE SENT TO THE CUSTOMER TO REQUEST THE IN-HOUSE CONTROL SLIDES, PATIENT SAMPLES AND CELL LINES FOR LOTS UNDER COMPLAINT. THIS WILL AID THE INVESTIGATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 675316 | BOND ORACLE HER2 IHC SYSTEM | BOND¿ ORACLE¿ HER2 IHC SYSTEM | MVC | LEICA BIOSYSTEMS NEWCASTLE LTD. | N/A | 27595 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 44 YR | Other | ||
| 2 | 64 YR | |||
| 3 | 64 YR |